Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | ADRB2 | P07550 | 4/20 | 0.33 |
| ▸ | ADRB1 | P08588 | 4/20 | 0.33 |
| ▸ | SIGMAR1 | Q99720 | 4/20 | 0.33 |
| ▸ | NR2E1 | Q9Y466 | 4/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.33 |
| ▸ | SLC6A4 | P31645 | 4/20 | 0.33 |
| ▸ | HTR1B | P28222 | 4/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.33 |
| ▸ | HTR2B | P41595 | 3/20 | 0.33 |
| ▸ | ADRB3 | P13945 | 3/20 | 0.33 |
| ▸ | HTR2A | P28223 | 3/20 | 0.33 |
| ▸ | HTR2C | P28335 | 3/20 | 0.33 |
| ▸ | HTR6 | P50406 | 3/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.33 |
| ▸ | SCN1A | P35498 | 2/20 | 0.33 |
| ▸ | SLC10A1 | Q14973 | 2/20 | 0.33 |
| ▸ | SCN2A | Q99250 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14452714 | 0.87 | KDM4E (0.32) | ALDH1A1HSD17B10KDM4E | |
| SCHEMBL7206268 | 0.81 | ALDH1A1 (0.36) | ALDH1A1HSD17B10KDM4EADRB2ADRB1 | |
| SCHEMBL13627007 | 0.79 | TNFRSF1A (0.30) | — | |
| SCHEMBL13627006 | 0.79 | ALDH1A1 (0.37) | ALDH1A1HSD17B10KDM4EHTR1BMAPK1 | |
| SCHEMBL13627002 | 0.78 | CYP2A6 (0.38) | ALDH1A1HSD17B10KDM4ECYP1A2MAPK1 | |
| SCHEMBL13291473 | 0.77 | GABRA1 (0.30) | — | |
| SCHEMBL14544191 | 0.75 | HTR1B (0.33) | ALDH1A1HSD17B10KDM4EHTR1BHTR1D | |
| SCHEMBL22071242 | 0.71 | KDM4E (0.33) | ALDH1A1HSD17B10KDM4E | |
| SCHEMBL7211545 | 0.70 | MAPT (0.36) | ALDH1A1HSD17B10KDM4ESLC6A4MAPK1 | |
| SCHEMBL14452664 | 0.68 | NCEH1 (0.42) | ALDH1A1HSD17B10KDM4ECYP1A2MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7615645-B2 | Method for the continuous production of aldehydes | BASF AKTIENGESELLSCHAFT (DE) | 2009-11-10 | — | — | US | disclosed |
| US-7241857-B2 | Method for producing allyl compound, and ether or ester compound produced thereby | MITSUBISHI CHEMICAL CORPORATION (JP) | 2007-07-10 | — | — | US | disclosed |
| US-20070083066-A1 | Method for the production of 1,7-octadiene and use thereof | BASF AKTIENGESELLSCHAFT (DE) | 2007-04-12 | — | — | US | disclosed |
| US-7173157-B2 | Method for producing an allyl compound | MITSUBISHI CHEMICAL CORPORATION (JP) | 2007-02-06 | — | — | US | disclosed |
| US-20070004939-A1 | Method for the continuous production of aldehydes | VOLLAND MARTIN | 2007-01-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070004939-A1 | Method for the continuous production of aldehydes | HRH4, HRH2, HRH3 | ALDH1A1 484/4885HSD17B10 658/4885KDM4E 4664/4885 |
| US-20070083066-A1 | Method for the production of 1,7-octadiene and use thereof | CYP51A1, MSMO1, HSD17B7 | ALDH1A1 82/4885HSD17B10 20/4885KDM4E 2956/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.